findmyKOL
Clinical trialNCT04808115WithdrawnPhase 1Interventional

IIT PH1 KDS-1001 in Patients With CML

SponsorDuke UniversityEnrollment0CML (Chronic Myelogenous Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Lindsay Rein, MD

    Assistant Professor of Medicine, Hematologic Malignancies & Cell Therapy

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2024
Primary completion
31 Dec 2027
Completion
31 Dec 2029
Last update posted
26 Nov 2024
Registered enrollment
0
Registry id
NCT04808115

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.